Exopharm
Johannes is based in Zurich, Switzerland and has a vast network in the life-science industry and is also a successful private investor in the biotech sector.
Johannes has a PhD from Edinburgh Napier University and is a Fellow of the Institute of Public Accountants (FIPA) Australia. Johannes also has a Diploma of International Business Administration from Furtwangen University and is currently studying towards a Master of Public Health at the University of Zurich.
Johannes brings with him a wealth of transferable skills – analytical precision, deep understanding of Finance and Accounting across continents, deal making, and thorough knowledge of the gene therapeutics and diagnostics market.
This person is not in any offices
Exopharm
Exopharm’s mission is to be a leader in the field of clinical human therapeutics using exosomes as regenerative medicine products.